Invesco Nasdaq Biotechnology ETF (NASDAQ:IBBQ – Get Free Report)’s share price rose 0.5% during trading on Tuesday . The company traded as high as $23.98 and last traded at $23.98. 4,029 shares changed hands during mid-day trading, a decline of 80% from the average daily volume of 19,948 shares. The stock had previously closed at $23.85.
Invesco Nasdaq Biotechnology ETF Trading Up 0.3 %
The company has a 50-day moving average price of $23.91 and a two-hundred day moving average price of $22.65. The stock has a market cap of $36.00 million, a P/E ratio of 17.39 and a beta of 0.61.
Invesco Nasdaq Biotechnology ETF Increases Dividend
The company also recently disclosed a quarterly dividend, which was paid on Friday, June 28th. Shareholders of record on Monday, June 24th were given a dividend of $0.0506 per share. This is a boost from Invesco Nasdaq Biotechnology ETF’s previous quarterly dividend of $0.04. The ex-dividend date was Monday, June 24th. This represents a $0.20 dividend on an annualized basis and a yield of 0.84%.
Institutional Investors Weigh In On Invesco Nasdaq Biotechnology ETF
Invesco Nasdaq Biotechnology ETF Company Profile
The Invesco Nasdaq Biotechnology ETF (IBBQ) is an exchange-traded fund that is based on the NASDAQ / Biotechnology index, a modified market-cap-weighted index of US biotechnology and pharmaceutical companies listed on the NASDAQ. IBBQ was launched on Jun 11, 2021 and is managed by Invesco.
Featured Articles
- Five stocks we like better than Invesco Nasdaq Biotechnology ETF
- 10 Best Airline Stocks to Buy
- 3 Leveraged ETFs to Multiply Returns
- What to Know About Investing in Penny Stocks
- A Tale of Two Titans: Unveiling the Value in Baidu and JD.com
- 3 REITs to Buy and Hold for the Long Term
- Is the AI-Capable iPhone 16 the Start of a Sales Super-Cycle?
Receive News & Ratings for Invesco Nasdaq Biotechnology ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Invesco Nasdaq Biotechnology ETF and related companies with MarketBeat.com's FREE daily email newsletter.